In some patients, tumors disappeared entirely, and tumor cells disappeared entirely from the bone marrow and liver.
A key finding is that the bigger the dosage, the bigger the impact. That's important because Blinotumomab has some nasty side effects, including fevers and chills, confusion and tremors.
Just as exciting, this is just the first of several such substances the company plans to test, against other types of cancer.
Immunotherapy once held great promise, but previous studies found that as tumors became more advanced they became invisible to the T-cells. Making them visible could make other treatments more effective.
Just don't get your hopes too high on this.
Remember, this is a Phase One study. Small population, small doses. We need to test dosing, test toxicity, and test it with larger populations. However a Phase Two study is already being planned on a similar drug against leukemia, the company said.